Purchase Order 75N93020P00478
Award Date 4/8/20
Potential Completion Date 2/24/22
Potential Value $264K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company. The $118,272.00 contract is for the provision of customized antibody expressions and plasmid preparations to support biomedical research and public health initiatives. The award has a completion date of November 1, 2020 and does not include a set-aside designation. Genscript...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $19,316.68 firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the provision of custom plasmid preparation services to support biomedical research and public health initiatives. Genscript has extensive experience providing specialized products and services to federal...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for gene synthesis services. The $17,000.35 contract has a completion date of December 30, 2020 and was awarded on December 31, 2019. The services provided under this contract supported biomedical research and public health initiatives carried out by the agency. Genscript has...
- This is a federal contract award made by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a biotechnology company, for the procurement of antibodies and gene expression products to support COVID-19 research. The one-year contract has a firm fixed price of $111,122.25 and was awarded on June 23, 2020, with a completion date of June 22, 2021. The contract does not have a set-aside designation. Genscript has previously received...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for antibody gene synthesis and production, valued at $16,974.27, on August 26, 2020. The order was firm fixed price with an ultimate completion date of February 6, 2021. Work was performed at Genscript's facility in Piscataway, New Jersey.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Genscript USA Inc., a biotechnology company, for the provision of DNA expression constructs. The contract has a potential value of $12,475.22 and a completion date of November 2, 2023. Genscript has provided similar services to federal agencies in the past, supporting biomedical research and public health initiatives...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, to provide antibody efficiency testing services. The $119,213.05 contract has a completion date of September 30, 2022 and does not utilize a set-aside designation. Genscript previously held a $1.5 million blanket purchase agreement with the U.S. Department of...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,779.98 firm fixed price purchase order to Genscript USA Inc. for transient expression, purification and plasmid preparation services in support of AMBIS program activities. Performance will take place in Piscataway, New Jersey over a two month period concluding on September 30, 2023. The contract calls for Genscript to deliver requested biomanufacturing...